SCHEMBL17636977

SCHEMBL17636977

CC1(C)c2ccccc2-c2cc(-n3c4ccccc4c4ccc(-c5ccc6c(c5)c5ccccc5n6-c5ccccc5)cc43)ccc21

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ HDAC4 P56524 1/20 0.34
▸ RXRA P19793 1/20 0.33
▸ RXRB P28702 1/20 0.33
▸ PTGER4 P35408 1/20 0.33
▸ PGR P06401 1/20 0.33
▸ TSPO P30536 1/20 0.32
▸ EDNRB P24530 1/20 0.30
▸ EDNRA P25101 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17636979 1.00 KDM4E (0.41) KDM4EATML3MBTL1HDAC4RXRA
SCHEMBL14212270 0.96 L3MBTL1 (0.44) KDM4EATML3MBTL1HDAC4RXRA
SCHEMBL17809418 0.95 KDM4E (0.43) KDM4EATML3MBTL1HDAC4RXRA
SCHEMBL15946285 0.94 KDM4E (0.40) KDM4EATML3MBTL1HDAC4PTGER4
SCHEMBL19195990 0.94 KDM4E (0.40) KDM4EATML3MBTL1HDAC4PTGER4
SCHEMBL16282979 0.93 KDM4E (0.39) KDM4EATML3MBTL1HDAC4RXRA
SCHEMBL14212280 0.93 KDM4E (0.41) KDM4EATML3MBTL1HDAC4RXRA
SCHEMBL14212282 0.93 KDM4E (0.41) KDM4EATML3MBTL1HDAC4RXRA
SCHEMBL16641550 0.93 KDM4E (0.40) KDM4EATML3MBTL1HDAC4RXRA
SCHEMBL17110008 0.93 KDM4E (0.38) KDM4EATML3MBTL1HDAC4RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11697645-B2 Heterocyclic compound, composition including heterocyclic compound, and organic light-emitting device including heterocyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-07-11 — — US disclosed
US-11697645-B2 Heterocyclic compound, composition including heterocyclic compound, and organic light-emitting device including heterocyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-07-11 — — US disclosed
US-20230140682-A1 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO LTD (KR) 2023-05-04 — — US disclosed
US-20230140682-A1 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO LTD (KR) 2023-05-04 — — US disclosed
US-11641774-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-05-02 — — US disclosed
US-11641774-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-05-02 — — US disclosed
US-20230126221-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-04-27 — — US disclosed
US-20230126221-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-04-27 — — US disclosed
US-11542252-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-01-03 — — US disclosed
US-11522140-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2022-12-06 — — US disclosed
US-20210184132-A1 COMPOUND, COMPOSITION INCLUDING THE SAME, LIQUID COMPOSITION, AND ORGANIC ELECTROLUMINESCENT DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-06-17 — — US disclosed
US-20200303652-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2020-09-24 — — US disclosed
US-10749113-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-08-18 — — US disclosed
US-20200207739-A1 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-07-02 — — US disclosed
US-20200212307-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-07-02 — — US disclosed
US-20200207732-A1 HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING HETEROCYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-07-02 — — US disclosed
US-20170054087-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2017-02-23 — — US disclosed
US-20170054087-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2017-02-23 — — US disclosed
US-20160093808-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-03-31 — — US disclosed
US-20160093808-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-03-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11697645-B2 Heterocyclic compound, composition including heterocyclic compound, and organic light-emitting device including heterocyclic compound CYP1B1, CYP1A1, CCNT1 KDM4E 4155/4885ATM 1467/4885L3MBTL1 517/4885
US-11542252-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound CCNT1, CCNA1, CYP1B1 KDM4E 3931/4885ATM 1887/4885L3MBTL1 175/4885
US-20210184132-A1 COMPOUND, COMPOSITION INCLUDING THE SAME, LIQUID COMPOSITION, AND ORGANIC ELECTROLUMINESCENT DEVICE TERT, TELO2, POT1 KDM4E 1003/4885ATM 1487/4885L3MBTL1 33/4885
US-20200207732-A1 HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING HETEROCYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND CYP1B1, CYP1A1, CCNT1 KDM4E 4155/4885ATM 1467/4885L3MBTL1 517/4885
US-20230140682-A1 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound CCNT1, CCNA1, CYP1B1 KDM4E 3931/4885ATM 1887/4885L3MBTL1 175/4885
US-20200212307-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND CCNB1, CCNA1, CCNT1 KDM4E 4280/4885ATM 827/4885L3MBTL1 285/4885
US-20200207739-A1 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound CCNT1, CCNA1, CYP1B1 KDM4E 3931/4885ATM 1887/4885L3MBTL1 175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback